Evidence-based Potential Therapeutic Applications of Cannabinoids in Wound Management

被引:5
作者
Kibret, Berhanu Geresu [1 ]
Patel, Sheel [2 ,3 ]
Niezgoda, Jonathan [4 ]
Guns, William [4 ]
Niezgoda, Jeffrey [4 ]
Gopalakrishnan, Sandeep [4 ]
Baban, Babak [5 ]
Cubillos, Paola [6 ]
Villeneuve, David [7 ,8 ]
Kumar, Pritesh [9 ,10 ]
机构
[1] William Paterson Univ, Dept Biol, Wayne, NJ 07470 USA
[2] Chicago Spine & Vasc Inst PC, Munster, IN USA
[3] AZH Wound Hyperbar & Vasc Ctr, Milwaukee, WI USA
[4] Univ Wisconsin, Coll Nursing, Milwaukee, WI 53201 USA
[5] Augusta Univ, Dent Coll Georgia, Dept Oral Biol & Diagnost Sci, Res, Augusta, GA USA
[6] Procanncol, Bogota, Colombia
[7] Canadore Coll Appl Arts & Technol, Dept Biotechnol, N Bay, ON, Canada
[8] Canadore Coll Appl Arts & Technol, N Bay, ON, Canada
[9] Canadore Coll Appl Arts & Technol, Cannabinoid Res, N Bay, ON, Canada
[10] PhytoSciences GmbH, Geneva, Switzerland
关键词
cannabidiol; cannabinoids; cannabis; integument; skin; tetrahydrocannabinol; wound; ENDOCANNABINOID SYSTEM; MOLECULAR CHARACTERIZATION; MEDICAL CANNABIS; CB2; RECEPTOR; ACTIVATION; INFLAMMATION; HYPERALGESIA; FIBROGENESIS; ANTAGONIST; LIGANDS;
D O I
10.1097/01.ASW.0000831920.15801.25
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND: Although wound management is a major component of all domains of healthcare, conventional therapeutics have numerous limitations. The endocannabinoid system of the skin, one of the major endogenous systems, has recently been connected to wound healing. Cannabinoids and their interactions with the endogenous chemical signaling system may be a promising therapeutic option because they address some of the fundamental pathways for physiologic derangement that underpin chronic integumentary wounds. RECENT ADVANCES: The therapeutic applications of cannabinoids are increasing because of their legalization and resulting market expansion. Recently, their immunosuppressive and anti-inflammatory properties have been explored for the treatment of wounds that are not effectively managed by conventional medicines. CRITICAL ISSUES: Failure to manage wounds effectively is associated with reduced quality of life, disability, mortality, and increased healthcare expenditures. Therapeutic options that can manage wounds effectively and efficiently are needed. In this review, the authors summarize recent advances on the use of cannabinoids to treat skin disorders with an emphasis on wound management. FUTURE DIRECTIONS: Effective wound management requires medicines with good therapeutic outcomes and minimal adverse effects. Despite the promising results of cannabinoids in wound management, further controlled clinical studies are required to establish the definitive role of these compounds in the pathophysiology of wounds and their usefulness in the clinical setting.
引用
收藏
页码:447 / 453
页数:7
相关论文
共 80 条
  • [1] The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity
    Alhouayek, Mireille
    Muccioli, Giulio G.
    [J]. TRENDS IN MOLECULAR MEDICINE, 2012, 18 (10) : 615 - 625
  • [2] Antibacterial cannabinoids from Cannabis sativa:: A structure-activity study
    Appendino, Giovanni
    Gibbons, Simon
    Giana, Anna
    Pagani, Alberto
    Grassi, Gianpaolo
    Stavri, Michael
    Smith, Eileen
    Rahman, Mukhlesur
    [J]. JOURNAL OF NATURAL PRODUCTS, 2008, 71 (08): : 1427 - 1430
  • [3] Exploiting Cannabinoid-Induced Cytotoxic Autophagy to Drive Melanoma Cell Death
    Armstrong, Jane L.
    Hill, David S.
    McKee, Christopher S.
    Hernandez-Tiedra, Sonia
    Lorente, Mar
    Lopez-Valero, Israel
    Anagnostou, Maria Eleni
    Babatunde, Fiyinfoluwa
    Corazzari, Marco
    Redfern, Christopher P. F.
    Velasco, Guillermo
    Lovat, Penny E.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (06) : 1629 - 1637
  • [4] Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease
    Basu, Sreemanti
    Dittel, Bonnie N.
    [J]. IMMUNOLOGIC RESEARCH, 2011, 51 (01) : 26 - 38
  • [5] Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders
    Baswan, Sudhir M.
    Klosner, Allison E.
    Glynn, Kelly
    Rajgopal, Arun
    Malik, Kausar
    Yim, Sunghan
    Stern, Nathan
    [J]. CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2020, 13 : 927 - 942
  • [6] Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression
    Blazquez, Cristina
    Salazar, Maria
    Carracedo, Arkaitz
    Lorente, Mar
    Egia, Ainara
    Gonzalez-Feria, Luis
    Haro, Amador
    Velasco, Guillermo
    Guzman, Manuel
    [J]. CANCER RESEARCH, 2008, 68 (06) : 1945 - 1952
  • [7] Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
    Borrelli, Francesca
    Fasolino, Ines
    Romano, Barbara
    Capasso, Raffaele
    Maiello, Francesco
    Coppola, Diana
    Orlando, Pierangelo
    Battista, Giovanni
    Pagano, Ester
    Di Marzo, Vincenzo
    Izzo, Angelo A.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2013, 85 (09) : 1306 - 1316
  • [8] The epidermis: a sensory tissue
    Boulais, Nicholas
    Misery, Laurent
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2008, 18 (02) : 119 - 127
  • [9] Wound microbiology and associated approaches to wound management
    Bowler, PG
    Duerden, BI
    Armstrong, DG
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (02) : 244 - +
  • [10] Cloning and molecular characterization of the rat CB2 cannabinoid receptor
    Brown, SM
    Wager-Miller, J
    Mackie, K
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2002, 1576 (03): : 255 - 264